I think we're somewhat forgetting that in 2003 there never was a drug held up to this kind of scrutiny. At that time the FDA accepted drugs that were within a certain tolerance, and I'd guess that Teva drug is within that tolerance.
What really happened is that the rules changed and now Teva is stuck with both feet in.
Did Teva do the homework that Momenta did? Absolutely not, but again they never would have spent maybe a couple of hundred million bucks to achieve that goal.
Now with Teva stuck in this fight I'm sure they'll just let it diminish over time and hope everyone forgets about it. Time is Teva's best friend right now.
Sooner or later we'll see what Teva's real strength is when we see their legal side.
By the way, Teva probably holds one of the best returns for its stockholders over the last 20 years. Somewhere around a 7000% return without counting the divs.
Market Data 
Markets 
AI
